SCHEMBL9733635

SCHEMBL9733635

Nc1ccc2c(c1)OC(=O)CC2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA9 Q16790 1/20 0.44
HSD17B10 Q99714 2/20 0.44
CASP1 P29466 1/20 0.44
CASP7 P55210 1/20 0.44
MAOB P27338 1/20 0.43
ALDH2 P05091 1/20 0.41
ALDH3A1 P30838 1/20 0.41
MAPT P10636 4/20 0.38
GAA P10253 3/20 0.38
LMNA P02545 2/20 0.38
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
GFER P55789 1/20 0.37
TSHR P16473 1/20 0.37
KDM4E B2RXH2 3/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
ATAD2 Q6PL18 1/20 0.36
TYMS P04818 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1854415 0.85 HSD17B10 (0.48) CA9HSD17B10CASP1CASP7MAOB
SCHEMBL18982690 0.78 MAOB (0.44) HSD17B10MAOBALDH2ALDH3A1TSHR
SCHEMBL5799941 0.77 ALDH2 (0.47) CA9MAOBALDH2ALDH3A1TSHR
SCHEMBL8759192 0.77 MAOB (0.43) MAOBALDH2ALDH3A1MAPTLMNA
SCHEMBL1013856 0.77 CA2 (0.50) CA9HSD17B10MAOBALDH2ALDH3A1
SCHEMBL13950589 0.77 MAOB (0.50) HSD17B10MAOBALDH2ALDH3A1TSHR
SCHEMBL29448284 0.77 CA2 (0.50) CA9HSD17B10MAOBALDH2ALDH3A1
SCHEMBL14192627 0.74 ALDH2 (0.51) HSD17B10MAOBALDH2ALDH3A1TSHR
SCHEMBL26314663 0.74 ALDH1A1 (0.43) CA9MAOBALDH2ALDH3A1MAPT
SCHEMBL27762668 0.74 PARP1 (0.45) HSD17B10MAOBALDH2ALDH3A1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115215848-B Protein kinase inhibitor and derivative thereof, preparation method, pharmaceutical composition and application 中国药科大学 2024-04-19 CN disclosed
CN-110467620-A Novel S type or R type tetrahydronaphthalene amides compound and its pharmaceutically acceptable salt and preparation method and application UNIV LIAONING 2019-11-19 CN disclosed
WO-2016187667-A1 FUNCTIONALISED AND SUBSTITUTED INDOLES AS ANTI-CANCER AGENTS NOVOGEN LIMITED (AU) 2016-12-01 WO disclosed
US-5081044-A Detection of hydrogen peroxide with optical indicator chalcogen compounds MILES INC. (US) 1992-01-14 US disclosed
EP-0156261-B1 FLUOROGENIC DIHYDROQUINOLONE AND DIHYDROCOUMARIN INDICATORS FOR HYDROGEN PEROXIDE MILES INC. (US) 1991-11-27 EP disclosed
US-4996332-A On oxidation produce fluorescent signals in analytical systems MILES INC. (US) 1991-02-26 US disclosed
US-4794079-A PEROXIDASE MILES INC. (US) 1988-12-27 US disclosed
US-4778893-A FLUORESCENT; OXIDATION OF CHALCOGENS WITH HYDROGEN PEROXIDE MILES INC. (US) 1988-10-18 US disclosed
EP-0121743-B1 OPTICAL INDICATOR CHALCOGEN COMPOUNDS AND USE MILES LABORATORIES, INC. (US) 1987-09-09 EP disclosed
US-4558130-A FLUORESCENCE ON OXIDATION BY HYDROGEN PEROXIDE; PEROXIDASE DETERMINATION MILES LABORATORIES, INC. (US) 1985-12-10 US disclosed
EP-0156261-A2 Fluorogenic dihydroquinolone and dihydrocoumarin indicators for hydrogen peroxide MILES INC. (US) 1985-10-02 EP disclosed
EP-0121743-A2 Optical indicator chalcogen compounds and use MILES LABORATORIES, INC. (US) 1984-10-17 EP disclosed